08043420100
What sets oncoplastic surgery apart in breast cancer treatment?
Oncoplastic surgery combines cancer removal and plastic surgery techniques simultaneously. This approach ensures optimal cosmesis, functional outcomes, and an enhanced quality of life for patients undergoing breast cancer treatment.
What is Sentinel Node Biopsy (SLNB), and why is it performed with breast conservation surgery?
Sentinel Node Biopsy (SLNB) is a procedure to determine if cancer has spread to the lymph nodes. It is often performed alongside breast conservation surgery to provide comprehensive information about the extent of the disease and guide further treatment decisions.
What is breast conservation surgery, and why is it recommended?
Breast conservation surgery involves removing the cancerous tissue while preserving the breast. It is recommended for its proven safety and reliability, particularly in younger patients, offering improved physical and psychological outcomes without compromising oncological effectiveness.
Can Peritoneal Surface Malignancy be transformed from palliative to curative?
Yes, with advanced therapeutic interventions like Cytoreductive Surgery with HIPEC and PIPAC, AIIO endeavors to convert palliative conditions associated with peritoneal surface malignancies into curative outcomes, offering renewed hope to patients.
How does AIIO ensure comprehensive care for patients with these malignancies?
AIIO adopts a multidisciplinary approach, collaborating with experts from various specialties, including surgery, chemotherapy, and supportive care. This ensures that patients receive holistic and personalized treatment plans.
What is the role of PIPAC in treating Peritoneal Surface Malignancy?
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) is a minimally invasive procedure involving the delivery of chemotherapy as an aerosol. It offers a targeted approach to treating peritoneal surface malignancies with fewer side effects.
How does Cytoreductive Surgery with HIPEC work?
Cytoreductive Surgery involves removing visible tumors in the peritoneal cavity, followed by HIPEC, where heated chemotherapy is circulated in the abdomen to destroy any remaining cancer cells. This combined approach aims to improve treatment efficacy.
Which cancers are addressed under Peritoneal Surface Malignancy?
Peritoneal Surface Malignancies can arise from various primary cancers, including those originating in the appendix, rectum, colon, stomach, ovaries, and other organs. AIIO's expertise covers a spectrum of these cancers.
What therapeutic procedures are offered for Peritoneal Surface Malignancy?
AIIO specializes in groundbreaking treatments like Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC). These procedures aim to transform palliative conditions into curative outcomes.
Why has AIIO been designated as a Center of Excellence?
AIIO has earned recognition as a Center of Excellence due to its expertise in treating peritoneal surface malignancies. The certification highlights our commitment to delivering advanced and comprehensive care for these challenging cancers.